Statement From the FDA on AquAdvantage Salmon

Posted on

Based on sound science and a comprehensive review, the FDA determined that food from AquAdvantage Salmon is as safe to eat and as nutritious as food from other non-GE, farm-raised Atlantic salmon. The FDA found no biologically relevant differences between AquAdvantage Salmon and its non-GE comparator. As part of the safety determination for food from AquAdvantage Salmon, the FDA performed an extensive analysis of the potential for food from AquAdvantage Salmon to pose additional allergenic risk to consumers. The agency determined that the data and sample size were sufficient to reliably detect a biologically relevant difference in allergenicity between AquAdvantage Salmon and non-GE Atlantic salmon. In addition, because all salmon are fish and fish are among the eight most allergenic foods in the United States, people who are allergic to salmon would most likely also be allergic to AquAdvantage Salmon. Therefore, people with fish allergies will generally avoid all fish, including but not limited to AquAdvantage Salmon.


The FDA’s approach to the safety assessment of food from AquAdvantage Salmon is consistent with that recommended by the Codex Alimentarius Commission, the World Health Organization and United Nations international food safety standard-setting body, in its Guideline for the Conduct of the Food Safety Assessment of Foods from Recombinant-DNA Animals (CAC/GL 68-2008). For more information about the studies used as the basis for the FDA’s decision, click here.